| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5857707 | Regulatory Toxicology and Pharmacology | 2013 | 5 Pages |
Abstract
⺠Risk assessment related to endocrine disruptors are challenged by recent studies. ⺠How to consider academic studies in a regulatory process? ⺠How to assess exposure for consumers? ⺠Which end point should be used for the selection of point of departure? ⺠The outcomes of an international workshop dedicated to these issues are proposed.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
C. Rousselle, J.N. Ormsby, B. Schaefer, A. Lampen, T. Platzek, K. Hirsch-Ernst, M. Warholm, A. Oskarsson, P.J. Nielsen, M.L. Holmer, C. Emond,